Inspiratory muscle training and functional capacity following coronary artery bypass grafting in high-risk patients: A pilot randomized and controlled trial.
breathing exercises
myocardial revascularization
postoperative complications
Journal
Journal of clinical and translational research
ISSN: 2424-810X
Titre abrégé: J Clin Transl Res
Pays: Singapore
ID NLM: 101667205
Informations de publication
Date de publication:
29 Aug 2022
29 Aug 2022
Historique:
received:
24
10
2021
revised:
04
02
2022
accepted:
01
05
2022
entrez:
17
8
2022
pubmed:
18
8
2022
medline:
18
8
2022
Statut:
epublish
Résumé
Coronary artery bypass graft (CABG) surgery is associated with worsened functional capacity, pulmonary complications, and increased length of hospital stay. These negative effects are exacerbated in patients who are at high risk of post-operative (PO) pulmonary complications before CABG. Inspiratory muscle training (IMT) has been shown to benefit CABG patients in their recovery process. However, in high-risk patients, there is little evidence to support the post-operative implementation of IMT for purposes of faster recovery. The aim of the study was to test the hypothesis that IMT improves the functional capacity, pulmonary complications, and length of hospital stay in patients prone to pulmonary complications who had undergone CABG. This is a pilot clinical trial carried out with patients at high risk for pulmonary complications in the PO phase. In the pre-operative period, maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP), and 6-min walk test (6MWT) were determined and administered. On the first PO day, patients were divided into two groups: A control group (CG) that received routine intervention and an IMT group that, in addition to routine care, was subjected to an IMT protocol until hospital discharge. On the day of discharge, the patients were reassessed with respect to ventilatory muscle strength, functional capacity, PO complications, and length of stay. Twenty-nine patients were evaluated, 15 in the CG and 14 in the IMT group. No significant differences were observed in relation to MIP (difference between the mean of -7 cmH IMT does not minimize the loss of functional capacity, but it reduces pulmonary complications and the length of stay of patients undergoing CABG who are preoperatively at a high risk of pulmonary complications. The increase in ventilatory muscle strength, associated with IMT, can reduce PO pulmonary complications, resulting in shorter hospital stays, and improved quality of life.
Sections du résumé
Background
UNASSIGNED
Coronary artery bypass graft (CABG) surgery is associated with worsened functional capacity, pulmonary complications, and increased length of hospital stay. These negative effects are exacerbated in patients who are at high risk of post-operative (PO) pulmonary complications before CABG. Inspiratory muscle training (IMT) has been shown to benefit CABG patients in their recovery process. However, in high-risk patients, there is little evidence to support the post-operative implementation of IMT for purposes of faster recovery.
Aim
UNASSIGNED
The aim of the study was to test the hypothesis that IMT improves the functional capacity, pulmonary complications, and length of hospital stay in patients prone to pulmonary complications who had undergone CABG.
Methods
UNASSIGNED
This is a pilot clinical trial carried out with patients at high risk for pulmonary complications in the PO phase. In the pre-operative period, maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP), and 6-min walk test (6MWT) were determined and administered. On the first PO day, patients were divided into two groups: A control group (CG) that received routine intervention and an IMT group that, in addition to routine care, was subjected to an IMT protocol until hospital discharge. On the day of discharge, the patients were reassessed with respect to ventilatory muscle strength, functional capacity, PO complications, and length of stay.
Results
UNASSIGNED
Twenty-nine patients were evaluated, 15 in the CG and 14 in the IMT group. No significant differences were observed in relation to MIP (difference between the mean of -7 cmH
Conclusion
UNASSIGNED
IMT does not minimize the loss of functional capacity, but it reduces pulmonary complications and the length of stay of patients undergoing CABG who are preoperatively at a high risk of pulmonary complications.
Relevance for Patients
UNASSIGNED
The increase in ventilatory muscle strength, associated with IMT, can reduce PO pulmonary complications, resulting in shorter hospital stays, and improved quality of life.
Identifiants
pubmed: 35975188
pii: jctres.08.202204.001
pmc: PMC9373720
Types de publication
Journal Article
Langues
eng
Pagination
266-271Informations de copyright
Copyright: © 2022 Author(s).
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest.
Références
Chron Respir Dis. 2019 Jan-Dec;16:1479973119843650
pubmed: 31131626
PLoS One. 2021 Aug 27;16(8):e0256609
pubmed: 34449776
J Cardiopulm Rehabil Prev. 2019 Nov;39(6):E19-E25
pubmed: 31343586
J Cardiothorac Vasc Anesth. 2018 Apr;32(2):748-759
pubmed: 29229259
J Cachexia Sarcopenia Muscle. 2017 Feb;8(1):89-101
pubmed: 27897405
Braz J Cardiovasc Surg. 2020 Dec 01;35(6):942-949
pubmed: 33113311
Eur J Prev Cardiol. 2020 Nov;27(17):1858-1861
pubmed: 32212843
Interact Cardiovasc Thorac Surg. 2008 Aug;7(4):539-43
pubmed: 18417519
Am J Respir Crit Care Med. 2002 Aug 15;166(4):518-624
pubmed: 12186831
Cochrane Database Syst Rev. 2015 Oct 05;(10):CD010356
pubmed: 26436600
Anesthesiology. 2019 Nov;131(5):1046-1062
pubmed: 31403976
J Cardiothorac Surg. 2016 Jul 08;11(1):99
pubmed: 27390849
COPD. 2020 Aug;17(4):378-383
pubmed: 32586145
Clin Rehabil. 2017 Apr;31(4):454-464
pubmed: 27154820
Chest. 2014 May;145(5):1016-1024
pubmed: 24337162
Mol Med Rep. 2020 Sep;22(3):1868-1882
pubmed: 32705173
Clin Respir J. 2020 Jun;14(6):521-526
pubmed: 32043736
Disabil Rehabil. 2018 Apr;40(8):864-882
pubmed: 28093920
Ann Rehabil Med. 2021 Aug;45(4):264-273
pubmed: 34496469
Braz J Med Biol Res. 1999 Jun;32(6):719-27
pubmed: 10412550
Mediators Inflamm. 2020 Jul 09;2020:9170640
pubmed: 32694929
J Thorac Cardiovasc Surg. 2014 Dec;148(6):3148-55.e1-5
pubmed: 25240522
Clin Rehabil. 2019 May;33(5):913-922
pubmed: 30722696
J Physiol. 2007 Nov 1;584(Pt 3):1019-28
pubmed: 17855758
PLoS One. 2020 Jul 9;15(7):e0235604
pubmed: 32645079
Anesthesiology. 2013 Jan;118(1):114-22
pubmed: 23196259
Braz J Cardiovasc Surg. 2016 Apr;31(2):140-4
pubmed: 27556313
J Appl Physiol (1985). 2013 May;114(9):1340-50
pubmed: 23449936
Curr Opin Clin Nutr Metab Care. 2013 May;16(3):243-50
pubmed: 23493017